Funding for this research was provided by:
Capital Markets CRC Limited (-)
NSW Ministry of Health (-)
University of Sydney (-)
HCF Research Foundation (-)
National Health and Medical Research Council (1109626)
Received: 19 October 2018
Accepted: 10 May 2019
First Online: 30 May 2019
Ethics approval and consent to participate
: This study was approved by the New South Wales Population and Health Services Research Ethics Committee (CI 2015/09/607).
: Not applicable.
: AGE receives salary support as the HCF Research Foundation Professorial Fellow, is a Ministerial appointee to the (Australian) Medicare Benefits Schedule (MBS) Review Taskforce, a Board Member of the NSW Bureau of Health Information (BHI) and is an advisor to Cancer Australia. He has received consulting fees from the Queensland and Victoria state government health departments and Private Healthcare Australia. TBP receives salary support via a doctoral scholarship from the Capital Markets Cooperative Research Centre-Health Market Quality Program, and a University Postgraduate Award from the University of Sydney. TBP is a member of the Editorial Board of <i>BMC Health Services Research</i>. He had no editorial role in the handling and review of this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.